Innovent Biologics Inc (6IB) — Free Cash Flow Generation Index
Innovent Biologics Inc (6IB) has a Free Cash Flow Generation Index of 1.97x as of December 2020. Free cash flow of €429.10 Million represents 2% of operating cash flow (€217.96 Million). Explore 6IB capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Innovent Biologics Inc Free Cash Flow Generation Index (2023–2025)
Historical FCF Generation Index trend for Innovent Biologics Inc across 3 annual periods. For the full cash flow conversion analysis, see Innovent Biologics Inc (6IB) cash conversion ratio.
Annual Free Cash Flow Generation for Innovent Biologics Inc (2023–2025)
Year-by-year Free Cash Flow Generation Index for Innovent Biologics Inc. Check Innovent Biologics Inc (6IB) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | €9.32 Billion | €10.00 Billion | €683.27 Million | ▲ +386.6% |
| 2024 | -0.33x | €-418.39 Million | €1.29 Billion | €1.71 Billion | ▲ +96.1% |
| 2023 | -8.36x | €-1.24 Billion | €147.81 Million | €1.38 Billion | — |